Chrysalis invests in businesses across the healthcare industry that offers innovative solutions to enhance productivity or to empower consumers to better manage their own health. Our investments in this sector focus on enabling technologies and new approaches to delivering services that can help all the participants in the healthcare system—doctors, hospitals, insurances companies and consumers—to improve outcomes and control costs.

Healthcare investments are led by David A. Jones, Jr. and Koleman Karleski. David has served on the board of Humana Inc. (NYSE:HUM) since 1993 where he was Chairman of the Board from 2005-2010.

In addition, Irv Bailey serves as lead director for Hospira, Inc. (NYSE: HSP).